7-deoxyadriamycin aglycone has been researched along with cimetidine in 1 studies
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmann, DL; Chang, MN; Creagan, ET; Frytak, S; Itri, LM; Long, HJ | 1 |
1 trial(s) available for 7-deoxyadriamycin aglycone and cimetidine
| Article | Year |
|---|---|
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Clinical Trials as Topic; DNA, Recombinant; Drug Administration Schedule; Drug Evaluation; Female; Humans; Interferon Type I; Male; Melanoma; Middle Aged; Naphthacenes; Time Factors | 1986 |